ATE295414T1 - Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen - Google Patents

Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen

Info

Publication number: ATE295414T1
Authority: AT; Austria
Prior art keywords: ctla; acid sequence; amino acid; seq; similar proteins
Prior art date: 1995-07-19

Application number

AT96927237T

Other languages

English (en)

Inventor

Kenneth Jacobs

Kerry Kelleher

Mckeough Carlin

Samuel Goldman

Debra Pittman

Sha Mi

Steven Neben

Joann Giannotti

Margaret Golden-Fleet

Original Assignee

Inst Genetics Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-19

Filing date

1996-07-18

Publication date

2005-05-15

1995-08-11 Priority claimed from US08/514,014 external-priority patent/US5707829A/en

1996-07-18 Application filed by Inst Genetics Llc filed Critical Inst Genetics Llc

2005-05-15 Application granted granted Critical

2005-05-15 Publication of ATE295414T1 publication Critical patent/ATE295414T1/de

Links

102000013691 Interleukin-17 Human genes 0.000 title abstract 3
108050003558 Interleukin-17 Proteins 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 2
108090000623 proteins and genes Proteins 0.000 title abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 6
150000001413 amino acids Chemical class 0.000 abstract 3
108090001005 Interleukin-6 Proteins 0.000 abstract 1
108090001007 Interleukin-8 Proteins 0.000 abstract 1
239000012634 fragment Substances 0.000 abstract 1
230000006698 induction Effects 0.000 abstract 1
230000014399 negative regulation of angiogenesis Effects 0.000 abstract 1
230000028327 secretion Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Diabetes (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Tropical Medicine & Parasitology (AREA)
Hematology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Rheumatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Neurology (AREA)
Endocrinology (AREA)
Neurosurgery (AREA)
Biochemistry (AREA)
Ophthalmology & Optometry (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Obesity (AREA)

AT96927237T 1995-07-19 1996-07-18 Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen ATE295414T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US50403295A	1995-07-19	1995-07-19
US08/514,014 US5707829A (en)	1995-08-11	1995-08-11	DNA sequences and secreted proteins encoded thereby
PCT/US1996/011889 WO1997004097A2 (en)	1995-07-19	1996-07-18	Human ctla-8 and uses of ctla-8-related proteins

Publications (1)

Publication Number	Publication Date
ATE295414T1 true ATE295414T1 (de)	2005-05-15

Family

ID=27054704

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96927237T ATE295414T1 (de)	1995-07-19	1996-07-18	Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen

Country Status (10)

Country	Link
EP (2)	EP0839196B1 (de)
JP (3)	JPH11510045A (de)
AT (1)	ATE295414T1 (de)
AU (1)	AU727480B2 (de)
CA (1)	CA2227220A1 (de)
DE (1)	DE69634726T2 (de)
DK (1)	DK0839196T3 (de)
ES (1)	ES2242966T3 (de)
PT (1)	PT839196E (de)
WO (1)	WO1997004097A2 (de)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6274711B1 (en)	1993-06-14	2001-08-14	Inserm, Institut National De La Sante Et De La Recherche Medicale	Purified mammalian CTLA-8 antigens and related reagents
US5707829A (en) *	1995-08-11	1998-01-13	Genetics Institute, Inc.	DNA sequences and secreted proteins encoded thereby
US7053190B2 (en)	1997-03-07	2006-05-30	Human Genome Sciences, Inc.	Secreted protein HRGDF73
EP0972029A1 (de)	1997-03-07	2000-01-19	Human Genome Sciences, Inc.	70 humane sekretierte proteine
US6878687B1 (en)	1997-03-07	2005-04-12	Human Genome Sciences, Inc.	Protein HMAAD57
EP1352962A1 (de) *	1997-03-07	2003-10-15	Human Genome Sciences, Inc.	186 humane sekretierte Proteine
US6420526B1 (en)	1997-03-07	2002-07-16	Human Genome Sciences, Inc.	186 human secreted proteins
WO2000004140A1 (en) *	1998-07-15	2000-01-27	Human Genome Sciences, Inc.	71 human secreted proteins
CA2283299A1 (en) *	1997-03-07	1998-09-11	Human Genome Sciences, Inc.	186 human secreted proteins
CA2284550A1 (en)	1997-03-21	1998-10-01	Human Genome Sciences, Inc.	87 human secreted proteins
EP0973896A2 (de) *	1997-04-10	2000-01-26	Genetics Institute, Inc.	Sekretierte exprimierte sequenzkennzeichen (sests)
JP2001519666A (ja) *	1997-04-10	2001-10-23	ジェネティックス・インスチチュート・インコーポレーテッド	分泌発現配列タグ（ｓＥＳＴｓ）
WO1998045437A2 (en) *	1997-04-10	1998-10-15	Genetics Institute, Inc.	SECRETED EXPRESSED SEQUENCE TAGS (sESTs)
EP1428833A3 (de) *	1997-06-06	2004-07-07	Human Genome Sciences, Inc.	207 menschliche sekretierte Proteine
CA2291260A1 (en) *	1997-06-06	1998-12-10	Human Genome Sciences, Inc.	207 human secreted proteins
US6548633B1 (en)	1998-12-22	2003-04-15	Genset, S.A.	Complementary DNA's encoding proteins with signal peptides
US6562578B1 (en)	1999-01-11	2003-05-13	Schering Corporation	IL-17-like cytokine binding compounds and antibodies
CA2321970A1 (en) *	1998-02-26	1999-09-02	Human Genome Sciences, Inc.	36 human secreted proteins
US7223727B2 (en)	1998-04-09	2007-05-29	Serono Genetics Institute S.A.	GSSP4 polynucleotides and polypeptides and uses thereof
US7060479B2 (en)	1999-12-08	2006-06-13	Serono Genetics Institute, S.A.	Full-length human cDNAs encoding potentially secreted proteins
US6251583B1 (en)	1998-04-27	2001-06-26	Schering Corporation	Peptide substrates for HCV NS3 protease assays
US7771719B1 (en)	2000-01-11	2010-08-10	Genentech, Inc.	Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
AU740405B2 (en)	1998-05-15	2001-11-01	Genentech Inc.	IL-17 homologous polypeptides and therapeutic uses thereof
CA2329274A1 (en) *	1998-05-29	1999-12-02	Steven M. Ruben	Interleukin-21
AU4682999A (en) *	1998-06-16	2000-01-05	Human Genome Sciences, Inc.	94 human secreted proteins
US7091315B1 (en)	1998-07-15	2006-08-15	Human Genome Sciences, Inc.	Protein HDPBQ71
JP2002525056A (ja) *	1998-09-17	2002-08-13	ザイモジェネティクス，インコーポレイティド	哺乳類のトランスフォーミング増殖因子β−９
PT1141297E (pt) *	1999-01-11	2010-01-06	Schering Corp	Citoquinas de mamíferos relacionadas com a interleucina-17. polinucleótidos que as codificam. utilizações
CA2296792A1 (en) *	1999-02-26	2000-08-26	Genset S.A.	Expressed sequence tags and encoded human proteins
EP1053751A1 (de) *	1999-05-17	2000-11-22	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Zusammensetzungen und Verfahren zur Behandlung von Zellproliferationskrankheiten
CA2387959A1 (en) *	1999-11-12	2001-05-17	Human Genome Sciences, Inc.	21 human secreted proteins
CA2382165A1 (en)	1999-12-08	2001-06-14	Genset S.A.	Full-length human cdnas encoding potentially secreted proteins
EP1259253A2 (de) *	2000-02-29	2002-11-27	ZymoGenetics, Inc.	Verfahren zur förderung der myelinproduktion durch schwann zellen
US7718397B2 (en)	2000-03-21	2010-05-18	Genentech, Inc.	Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
EP2020239A1 (de) *	2000-04-18	2009-02-04	Schering Corporation	Verwendung von IL-174 Agonisten zur Behandlung der Infektionskrankheiten
US20030096969A1 (en)	2000-06-02	2003-05-22	Genentech, Inc.	Secreted and transmembrane polypeptides and nucleic acids encoding the same
CN1329090A (zh) *	2000-06-21	2002-01-02	上海博德基因开发有限公司	一种新的多肽——人自身免疫疾病相关蛋白10和编码这种多肽的多核苷酸
MXPA03003407A (es)	2000-10-18	2004-05-04	Immunex Corp	Metodos para el tratamiento de artritis reumatoide usando antagonistas il-17.
WO2005010044A2 (en) *	2003-07-08	2005-02-03	Genentech, Inc.	Il-17 a/f heterologous polypeptides and therapeutic uses thereof
WO2003034984A2 (en) *	2001-10-19	2003-05-01	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
JP2011516026A (ja) *	2002-11-26	2011-05-26	ジェネンテック・インコーポレーテッド	免疫関連疾患の治療のための組成物と方法
SI1983000T1 (sl)	2003-11-21	2015-12-31	Ucb Biopharma Sprl	Postopek za zdravljenje multiple skleroze z zaviranjem aktivnosti il-17
GB0417487D0 (en)	2004-08-05	2004-09-08	Novartis Ag	Organic compound
WO2007106769A2 (en)	2006-03-10	2007-09-20	Zymogenetics, Inc.	Antibodies that bind both il-17a and il-17f and methods of using the same
US7790163B2 (en)	2006-03-10	2010-09-07	Zymogenetics, Inc.	Antibodies that bind both IL-17A and IL-17F and methods of using the same
US7833527B2 (en)	2006-10-02	2010-11-16	Amgen Inc.	Methods of treating psoriasis using IL-17 Receptor A antibodies
ES2465223T3 (es)	2007-04-27	2014-06-05	Zymogenetics, Inc.	Antagonistas de IL-17A, IL-17F e IL-23P19 y procedimientos de uso
CA2721713C (en)	2008-05-05	2019-07-09	Novimmune Sa	Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
EP2427203B1 (de)	2009-05-05	2018-10-17	Novimmune S.A.	Anti-il-17f-antikörper und deren verwendung
US20120076754A1 (en) *	2009-05-20	2012-03-29	Ziad Mallat	Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
SI3295957T1 (sl)	2010-01-15	2020-02-28	Kirin-Amgen, Inc.	Formulacija protitelesa proti IL-17RA in terapevtski režim za zdravljenje luskavice
ME02734B (de)	2011-01-14	2017-10-20	Ucb Biopharma Sprl	Antikörpermodule zur bindung an il-17a und il-17f
UA117218C2 (uk)	2011-05-05	2018-07-10	Мерк Патент Гмбх	Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6562333B1 (en) *	1993-06-14	2003-05-13	Schering Corporation	Purified mammalian CTLA-8 antigens and related reagents
MX9707021A (es) *	1995-03-23	1997-11-29	Immunex Corp	Receptor de il-7.
US5707829A (en) *	1995-08-11	1998-01-13	Genetics Institute, Inc.	DNA sequences and secreted proteins encoded thereby

1996
- 1996-07-18 AU AU67123/96A patent/AU727480B2/en not_active Ceased
- 1996-07-18 EP EP96927237A patent/EP0839196B1/de not_active Expired - Lifetime
- 1996-07-18 JP JP9506846A patent/JPH11510045A/ja not_active Withdrawn
- 1996-07-18 CA CA002227220A patent/CA2227220A1/en not_active Abandoned
- 1996-07-18 DK DK96927237T patent/DK0839196T3/da active
- 1996-07-18 AT AT96927237T patent/ATE295414T1/de not_active IP Right Cessation
- 1996-07-18 DE DE69634726T patent/DE69634726T2/de not_active Expired - Lifetime
- 1996-07-18 PT PT96927237T patent/PT839196E/pt unknown
- 1996-07-18 WO PCT/US1996/011889 patent/WO1997004097A2/en not_active Ceased
- 1996-07-18 EP EP05009086A patent/EP1591529A3/de not_active Withdrawn
- 1996-07-18 ES ES96927237T patent/ES2242966T3/es not_active Expired - Lifetime
2007
- 2007-11-21 JP JP2007301924A patent/JP4319686B2/ja not_active Expired - Fee Related
2009
- 2009-04-02 JP JP2009090326A patent/JP2009197000A/ja active Pending

Also Published As

Publication number	Publication date
DE69634726T2 (de)	2006-05-04
CA2227220A1 (en)	1997-02-06
AU6712396A (en)	1997-02-18
JP4319686B2 (ja)	2009-08-26
DK0839196T3 (da)	2005-09-12
DE69634726D1 (de)	2005-06-16
PT839196E (pt)	2005-09-30
AU727480B2 (en)	2000-12-14
EP0839196B1 (de)	2005-05-11
WO1997004097A2 (en)	1997-02-06
EP0839196A2 (de)	1998-05-06
JP2009197000A (ja)	2009-09-03
EP1591529A3 (de)	2005-11-09
JPH11510045A (ja)	1999-09-07
WO1997004097A3 (en)	1997-09-12
JP2008131942A (ja)	2008-06-12
EP1591529A2 (de)	2005-11-02
MX9800507A (es)	1998-05-31
ES2242966T3 (es)	2005-11-16

Legal Events

Date

Code

Title

Description

2006-01-15

UEP

Publication of translation of european patent specification

Ref document number: 0839196

Country of ref document: EP

2010-04-15

REN

Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
DE69634726D1 (de)	2005-06-16	Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
NO20074516L (no)	2000-07-20	Pattedyrcytokinlignende polypeptid-1
DK0397633T3 (da)	1996-01-02	Fibronectinbindende protein samt fremstilling deraf
DE60030769D1 (de)	2006-10-26	Verfahren zur behandlung von entzündungen
DK150992A (da)	1992-12-17	Fremgangsmaade til fremstilling af et polypeptidfragment af faktor viii:c, dna-sekvens og ekstrachromosomalt element indeholdende en saadan dna-sekvens, som koder herfor
ATE339878T1 (de)	2003-12-15	Myc-bindende zinkfinger-proteine, ihre herstellung und ihre verwendung
ATE378408T1 (de)	2007-11-15	Transformierender wachstumsfaktor beta-9 (ztgfss9) aus säugetieren
ATE403726T1 (de)	2008-08-15	Cytokin-proteinfamilie
NO882380D0 (no)	1988-05-31	Fibfonektin-bindende protein, samt fremstilling derav.
ATE534742T1 (de)	2011-12-15	Polypeptide und nukleinsäuren von phorphorymonas gingivalis
DE69432427D1 (de)	2003-05-08	Tomate xyloglukan endotransglykosylase
ATE432287T1 (de)	2009-06-15	Peptidfragmente mit den zelltod verhindernder aktivität
DK0580672T3 (da)	1997-07-07	Syntetisk CDw52-(CAMPATH-1)-peptidantigen
ATE209252T1 (de)	2001-12-15	Rekombinante d-hydantoinase, verfahren zur herstellung und verwendung
CY1111763T1 (el)	2015-10-07	ΑΝΤΙΣΩΜΑΤΑ ΕΝΑΝΤΙΟΝ ΤΗΣ ΠΡΩΤΕΪΝΗΣ p51
SE8801723D0 (sv)	1988-05-06	Fibronectin binding protein as well as its preparation
DE59410423D1 (de)	2006-01-12	Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DE59108261D1 (de)	1996-11-14	Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
DE60138885D1 (de)	2009-07-16	Polypeptide mit aktivität der stimulierung von neutrophilen